dr. mesa on jak inhibitors in the pipeline for myelofibrosis
Published 4 years ago • 593 plays • Length 1:42Download video MP4
Download video MP3
Similar videos
-
1:54
dr. mesa discusses jak inhibitors for myelofibrosis
-
1:14
dr. mesa on the emergence of jak inhibitors in myelofibrosis
-
0:58
dr. mesa on challenges with jak inhibitors in myelofibrosis
-
1:08
dr. mesa on unanswered questions regarding jak inhibitors in myelofibrosis
-
1:14
dr. mesa on the safety profiles of jak inhibitors in myelofibrosis
-
2:22
dr. mesa on the evolving role of jak2 inhibitors in myelofibrosis
-
1:29
dr. mesa on the fda approval of fedratinib in myelofibrosis
-
22:26
what's your approach? treating myelofibrosis
-
1:47
dr. oh on the development of jak inhibitors in myelofibrosis
-
0:53
investigating the place of jak inhibitors in the treatment of myelofibrosis
-
37:14
risk-adapted treatment in myelofibrosis: jak inhibitors and novel combination therapies
-
25:13
update on jak inhibitors for myelofibrosis: there is more than one
-
1:32
dr. mesa on emerging therapies in myelofibrosis
-
1:10
dr. ruben mesa on comfort-1 for myelofibrosis
-
3:48
jak inhibition for the early treatment of myelofibrosis
-
1:42
dr. mesa on ruxolitinib vs fedratinib in myelofibrosis treatment
-
1:34:09
jak inhibitors in myelofibrosis: expert insights on cases in personalizing therapy
-
6:54
role for jak inhibition in myelofibrosis
-
1:52
dr. mesa on investigative therapies in myelofibrosis